ECLIPSEIII, NCT02859129: Study to Evaluate the 2-Way Interaction Between Multiple Doses of Epanova™ and a Single Dose of Rosuvastatin (Crestor®) |
|
|
| Completed | 1 | 114 | US | rosuvastatin 40 mg tablet, Crestor, Epanova™ QD (2 x 1 g capsules), omega-3 carboxylic acids, Multiple doses of 4 g Epanova™ with single of rosuvastatin 40 mg dose, Multiple (20) oral doses of 2 g Vascepa® every 12 hours, icosapent ethyl | AstraZeneca | Hypertriglyceridemia | 11/13 | 11/13 | | |
